Royal Hospital For Women   Report issue

Academic/Hospital Phase 4
Founded: Sydney Australia (1820)

Organization Overview

First Clinical Trial
2019
NCT04044703
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Royal Hospital For Women

Active Ingredients

Drugs in Phase 4 Trials (1)

vancomycin (Vancocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacteremia (Phase 4)

Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1